MSD Pharmaceuticals Private Limited Sustainability Profile
MSD Pharmaceuticals Private Limited, commonly known as MSD, is a leading player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has made significant strides in various operational regions, focusing on innovative healthcare solutions that cater to diverse medical needs. Specialising in prescription medicines, vaccines, and biologics, MSD is renowned for its commitment to research and development, which has led to the introduction of unique therapies in areas such as oncology, infectious diseases, and immunology. The company’s robust pipeline and strategic partnerships have solidified its market position, making it a trusted name in the healthcare sector. With a strong emphasis on quality and patient-centric solutions, MSD Pharmaceuticals continues to achieve notable milestones, contributing to improved health outcomes across India and beyond.
DitchCarbon Score
How does MSD Pharmaceuticals Private Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MSD Pharmaceuticals Private Limited's score of 63 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MSD Pharmaceuticals Private Limited, headquartered in India, currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of Merck & Co., Inc., and therefore, any climate commitments or emissions data may be influenced by its parent organisation's initiatives. As part of its corporate family relationship, MSD Pharmaceuticals aligns with the sustainability and climate strategies set forth by Merck & Co., Inc. This includes adherence to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for MSD Pharmaceuticals are not detailed in the available data. The company is committed to broader climate initiatives, although no specific climate pledges or reduction targets have been disclosed. As a subsidiary, MSD Pharmaceuticals may benefit from the sustainability frameworks and goals established by Merck & Co., Inc., which are designed to reduce overall carbon emissions and enhance environmental stewardship across its operations. In summary, while specific emissions data and reduction targets for MSD Pharmaceuticals Private Limited are not available, the company is positioned within a corporate structure that prioritises climate action and sustainability through its relationship with Merck & Co., Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,532,400,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is MSD Pharmaceuticals Private Limited's Industry?
How Carbon Intensive is MSD Pharmaceuticals Private Limited's Location?
MSD Pharmaceuticals Private Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MSD Pharmaceuticals Private Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
